Speaker Profile
Biography
Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He has also been an active Board Member and or Founder for over a dozen privately held and publicly traded companies. Howard has published over 600 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Burns Blaxall
PMWC Award Ceremony Honorees
• Euan Ashley, Stanford
• Jeff Balser, VUMC
Precision Medicine at Scale, Lessons from Vanderbilt
• Jeffrey R. Balser, Vanderbilt
Implementing Precision Medicine at Scale: Health Systems and Policy Perspectives
• Jeffrey Balser, Vanderbilt
• Euan Ashley, Stanford
• Sasa Jenko, European Commission
Keynote
• Lee Hood, Phenome Health
Keys to Successful Implementation of a Precision Medicine Program
• Chair: Howard McLeod, GeneDx
• David E. Lanfear, Henry Ford Health
• Kevan Simms, Ochsner Health
Key Players in Successful Implementation – Beyond Oncology
• Chair: Damon Hostin, Illumina
• Shaista Malik, UC Irvine
Precision Medicine at Scale: Lessons from a Statewide Genomic Initiative
• Chair: Premal Shah, MyOme
Achieving Comprehensive Precision Medicine
• Chair: Burns Blaxall
• Trish Brown, GeneDx
• Sarah Hersey, BMS
• Euan Ashley, Stanford




